BMS-986278, a lysophosphatidic acid 1 (LPA1) receptor antagonist, in healthy participants: A single/multiple ascending dose (SAD/MAD) phase 1 study

Authors
Category Primary study
JournalEuropean Respiratory Journal
Year 2019
This article has no abstract
Epistemonikos ID: ccc1301ddecae66afde3abd42821e0c7fb0b1181
First added on: Feb 11, 2025